Hemolytic Disease of the Fetus and Newborn (by LabCE)

2 P.A.C.E. contact hour(s)

(based on 793 customer ratings)

Author: Pat Letendre, MEd
Reviewer: Erin Tretter, MT(ASCP)

Course provided by LabCE.

This course presents current information related to hemolytic disease of the fetus and newborn (HDFN). It provides you with an opportunity to review and update your knowledge of significant aspects of HDFN and its laboratory investigation and prevention. This course provides a broad overview of many important topics including causative antibodies, laboratory findings in severe HDFN, and pre- and postnatal treatments. Rh immune globulin (RhIg) is covered in depth, since it prevents the most severe form of HDFN and is one of the biggest success stories of modern medicine.

See more courses in: Blood Banking / Immunohematology

Included In These Course Packages

Continuing Education Credits

P.A.C.E.® Contact Hours (acceptable for AMT, ASCP, and state recertification): 2 hour(s)
Course number 578-031-16, approved through 4/30/2018
Florida Board of Clinical Laboratory Personnel Credit Hours - General (Blood Banking / Immunohematology): 2 hour(s)
Course number 20-547689, approved through 9/1/2018

Objectives

  • Describe and interpret typical clinical symptoms and associated laboratory test results in hemolytic disease of the fetus and newborn (HDFN) and relate findings to the pathogenesis of HDFN and its treatment.
  • Describe the progression of HDFN due to anti-D historically and discuss the effect of Rh immune globulin (RhIg) and other factors on its incidence.
  • Compare and contrast ABO HDFN and HDFN due to anti-D and other antibodies in terms of clinical symptoms, fetal monitoring procedures, laboratory investigation, typical test results, and criteria for donor RBC transfusions.
  • Identify current best practices for perinatal testing programs and investigation of HDFN and interpret serologic tests done on the mother, father, and fetus / newborn.
  • Discuss the sources of RhIg, its preparation, constituents, safety, types, mechanisms of action, criteria for administration, dosage calculation, and causes of failures.
  • Describe the principles, uses, and limitations of the rosette test, Kleihauer-Betke test, and flow cytometry used in perinatal testing programs.

Customer Ratings

(based on 793 customer ratings)

Users Also Bought

13.5 P.A.C.E.® contact hours
(3 ratings) $44 Add to cart
1 P.A.C.E.® contact hour
(12 ratings) $30 Add to cart
2 P.A.C.E.® contact hours
(2,800 ratings) $25 Add to cart
13.5 P.A.C.E.® contact hours
(11 ratings) $44 Add to cart

Course Outline

  • Pathophysiology of HDFN and Blood group systems most commonly implicated in the disease
      • Introduction
      • Development of Anti-D
      • Factors That Affect Production of Anti-D
      • Primary versus Secondary Response
      • Pathophysiology in Severe HDFN Due to Anti-D
      • HDFN Due to Anti-D
      • ABO HDFN
      • ABO HDFN: Diagnostic Tests
      • ABO HDFN: Expected Findings
      • ABO HDFN: Treatment
      • HDFN Due to Other Antibodies
  • Fetal Monitoring and HDFN Treatments
      • Fetal Monitoring
      • Prenatal Treatment
      • Choosing Donor RBC for IUT and IVT
      • Postnatal Treatment: Exchange Transfusion
      • Criteria for Transfused Red Blood Cells
      • Other Postnatal Treatment
  • Perinatal Testing Programs
      • Introduction
      • HDFN Diagnosis and Management
      • Newborn Serologic Testing Protocols
      • Molecular Genotyping
      • Molecular Genotyping: Differentiating Between Weak D and Partial D
      • Determining Risk for HDFN Using Molecular Genotyping
      • Follow-up Investigative Tests (Mother)
      • Follow-up Investigative Tests (Father)
      • Follow-up Investigative Tests (Fetus)
      • Follow-up Investigative Tests (Newborn)
  • Review of Rh Immune Globulin
      • Rh Immune Globulin (RhIg)
      • Constituents
      • Use in Pregnancy
      • Related Uses
      • RhIg and Rh Complexity
      • RhIg and Variants of D
      • RhIg Policies for Weak D
      • International RhIg Policies
      • Clinical Relevance of D Phenotypes
      • RhIg Dosage
      • RhIg 'Failures'
      • Passive Anti-D following RhIg Administration
      • Protocols to Deal with RhIg-Derived Anti-D
  • Post-delivery Testing of RhIg Candidates
      • Introduction
      • Screening for Fetomaternal Hemorrhage (FMH)
      • Rosette Test
      • Quantifying FMH
      • Kleihauer-Betke (KB) Test
      • Flow Cytometry
      • Calculating RhIg Dosage
  • Summary and Conclusions
      • Main Learning Goals
  • Further Reading
      • Resources
  • References
      • References

Additional Information

Level of instruction: Intermediate

Intended Audience: Clinical laboratory technologists, technicians, and pathologists. This course is also appropriate for clinical laboratory science students and pathology residents.
 
Author information:
 
Pat Letendre, MEd is a laboratory technologist, educator, and consultant. Currently, she consults full-time in the areas of transfusion medicine, education, professional development, and use of the Internet in education. Ms. Letendre is the Webmaster for Canada's transfusion safety officers and the TraQ website coordinator. She holds a Masters of Education degree in adult education from the University of Alberta and a Bachelor of Science degree from the University of Manitoba.  
   
Reviewer information:

Erin Tretter, MT(ASCP), is currently the STAT Laboratory Supervisor at Penn Presbyterian Medical Center in Philadelphia, PA. She received her BS in Medical Technology from California University of Pennsylvania and has nearly 8 years of experience as a Generalist, including Blood Bank, Hematology and Chemistry. Erin is the Blood Bank Clinical Instructor for the Clinical Laboratory Science Program at St. Christopher’s and has 4 years experience teaching immunohematology concepts and laboratory procedures to Medical Technology students. She has also provided blood bank training for laboratory technologists and medical students. Erin is currently obtaining a Master’s in Business Administration from Florida Institute of Technology where she is a member of the Phi Kappa Phi Honor’s Society.

Course information:

This course will:

  • Recap relevant background information on HDFN and its treatment
  • Review the characteristics and uses of Rh immune globulin (RhIg)
  • Discuss typical laboratory findings and their interpretations
  • Examine current best practices in perinatal testing programs

It is a companion course to "Rh negative female with anti-D at delive

Keywords

These are the most common topics and keywords covered in Hemolytic Disease of the Fetus and Newborn (by LabCE):

complements red blood cells combinations utero genotype placenta amniocentesis rosette pregnancies fetomaternal investigative kleihauer-betke percutaneous liver reticulocyte oxygen transfused anti-fya symptom antenatally abdominal pregnancy pubs newborn diagnostic diagnosis postnatal jaundice rh-positive phenotype d-negative ultrasonography anti-a bilirubin fetuses villus serologic prenatal capillaries homozygous elution donors antigens guidelines allele sensitivity assessment graft-versus-host vial cell-free titer diagnose rh-negative fetus fat-rich blood cells safety immunogenic excretable immunized titration medicine bringing dats down-regulation anti-k vials hydrops alleles management epitopes phototherapy agglutination dcece rhigs trauma immunohematology leukoreduced heterozygous bleeds inject antiglobulin plasma cells clinical protocols genotyping globulin antibodies sonography sensitize cerebral symptoms rigor enzyme plasma d-positive glucuronyl fetal post-delivery gene rhce dosage perinatal identification antigen pregnant survey hdfn kell caucasians harmless hematocrit hemoglobin antigen-specific decimal hemolysis fathers intravenous ivts iuts anti-e immunization disease physician antibody-sensitized intrauterine antigen-negative cytometry prophylaxis water-soluble hyperbilirubinemia brain samples fresher tamul reconstituted hemolytic neonatal hypoxia-induced doubling transferase serum transfusion ectopic fetal-maternal anemia doppler cordocentesis heart donor mmol transfusions irradiated methods platelet gestational antepartum umbilical crossmatched diagnosing reagents hemorrhage prescribed antenatal gestation appears amniotic fluid procedures kernicterus rbcs genetics extensively exposure laboratory treatment soluble contains immune anti-d previa phenotypes anti-b antibody chorionic concentration
How to Subscribe
MLS & MLT Comprehensive CE Package (by LabCE)
Package of 99 online courses$95
Add to cart
Single online course$25
Add to cart
  • Order for instant access through any computer, any browser.
  • No shipping, faxing, or waiting for certificates.
  • Print or save your certificate of completion as soon as you've completed the course.
  • You'll have 90 days to complete your purchased courses.
Course provided by LabCE.
BK-Pos arrows


p19 table


Primary vs secondary immune response



 
ASCLS CE's design and platform are provided by MediaLab, Inc.